A. Maciąg

ROS 1 and EGFR next-generation tyrosine kinase inhibitors in advanced non-small-cell lung cancer

M. Krzakowski, P. Rutkowski, P. Golusiński, 2019 .

Blood selenium concentrations and glutathione peroxidase activities in patients with breast cancer and with advanced gastrointestinal cancer.

A. Nowicki, U. Trafikowska, B. Zachara, 1991, Journal of trace elements and electrolytes in health and disease.

Decreased Selenium Concentration and Glutathione Peroxidase Activity in Blood and Increase of These Parameters in Malignant Tissue of Lung Cancer Patients

J. Skokowski, B. Zachara, W. Lambrecht, 1997, Lung.

The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors

W. Owczarek, R. Czajkowski, Magdalena Ciążyńska, 2017, Advances in Dermatology and Allergology.

Management of dermatological adverse events during nivolumab treatment

W. Owczarek, M. Słowińska, A. Maciąg, 2017 .

Interactions between essential and toxic elements in lead exposed children in Katowice, Poland.

M. Vahter, A. Schütz, B. Akesson, 1998, Clinical biochemistry.

Vismodegib in the treatment of basal cell carcinoma — Polish clinical experience in the frame of therapeutic program

P. Rutkowski, P. Golusiński, W. Owczarek, 2019, Oncology in Clinical Practice.

Changes in blood selenium and glutathione concentrations and glutathione peroxidase activity in human pregnancy.

C. Wardak, B. Zachara, A. Maciąg, 1993, Gynecologic and obstetric investigation.

Selenium, glutathione, and glutathione peroxidase in blood and tissues of breast cancer patients

A. Nowicki, B. Zachara, A. Maciąg, 1993 .